Patent Assignment
Reel/Frame 039868/0084
Confirmatory License
Recorded: 2016-09-27
Pages: 2
USPTO hasn’t posted the scanned image for this recording yet. Order a certified copy below.
Order Certified Copy
Assignor
DANA-FARBER CANCER INSTITUTE
Executed: 2016-09-27
Assignee
NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR
6705 ROCKLEDGE DRIVE, SUITE 310, BETHESDA, MARYLAND, 20892-7980
Covered Property
(1)
Method of Using Sfv HUTAT2 in Intracellular Targeting Generation of Ln-Hsfvtat Packaging Cell Lines
Patent:
6,479,284 →
Application:
09/660,169 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 14, 2000
From: MARASCO, WAYNE A.; LAVECCHIO, JOYCE; MHASHILKAR, ABNER M.
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 011340/0597 →
Assignment of Assignor's Interest
Dec 14, 2000
From: DAVID, RING
To: CHIRON CORPORATION
Reel/Frame 011340/0618 →
Assignment of Assignor's Interest
Jun 15, 2001
From: RAMSTEDT, URBAN; EBERHARDT, BRIDGET; PORTER-BROOKS, JULIE
To: AVANT IMMUNOTHERAPEUTICS, INC.
Reel/Frame 011901/0711 →
Confirmatory License
Jul 14, 2008
From: DANA-FARBER CANCER INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021232/0787 →
Change of Name
Mar 9, 2009
From: AVANT IMMUNOTHERAPEUTICS, INC. (NEEDHAM, MASSACHUSETTS)
To: CELLDEX THERAPEUTICS, INC.
Reel/Frame 022380/0239 →